Pyrazolam
Aliases: Sh-i-04
Summary
Pyrazolam is a novel depressant substance of the benzodiazepine class. Pyrazolam was originally developed at Hoffman-La Roche in the 1970s and subsequently "rediscovered" and sold as a research chemical starting in 2012. Subjective effects include sedation, anxiety suppression, muscle relaxation, disinhibition, and euphoria.
Dose Information
| ROA | Light | Common | Strong | Heavy |
|---|---|---|---|---|
| Oral | 0.5-0.75mg | 0.75-1.5mg | 1.5-3mg | 3mg+ |
Benzo Equivalence Calculator
| Substance | Equivalent Dose | Potency |
|---|
⚠ These are approximate equivalences for educational and cross-tapering reference. Individual response, tolerance, and half-life differences mean actual equivalence varies. Always consult a healthcare provider for tapering guidance.
Onset, Duration & After-effects
| ROA | Onset | Peak | Offset | Total |
|---|---|---|---|---|
| Oral | 10-15 min | 1-3 hrs | 4-6 hrs | 5.2-9.2 hrs |
Effect Profile
9 reportsScores (1–10) curated from multiple sources:
- Effect keyword matching from PsychonautWiki catalog
- Weighted by importance: core (×3), major (×2), minor (×1)
Strong anxiolysis and cognitive impairment with moderate euphoria, mild sedation
Tolerance
Tolerance Decay
As with other benzodiazepines, tolerance to sedative/hypnotic effects can build within days of repeated dosing; anxiolytic tolerance may develop more gradually. Rough recovery to baseline often requires several weeks off. Estimates here are conservative and based on general benzo patterns and user reports, not controlled studies.
Cross-Tolerances
Effects
Aggregated from 9 Erowid experience reports